Table S2 from Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors
Autor: | Ramesh K. Ramanathan, Louie Naumovski, Daniel Afar, Edward Reilly, Lan Wang, Huibin Yue, Shekman Wong, Monica Motwani, Peter Ansell, Chia-Chi Lin, Chia Jui Yen, Yoon-Koo Kang, Ravi Salgia, Patricia LoRusso, John H. Strickler |
---|---|
Rok vydání: | 2023 |
DOI: | 10.1158/1535-7163.22518666 |
Popis: | Additional details for MET-amplified patients with one or more postbaseline tumor assessment (n=9). |
Databáze: | OpenAIRE |
Externí odkaz: |